ABSTRACT:
Over the past few decades, there has been rapid growth in the field of herbal medicine. While many traditional herbal remedies are effective, they often lack proper standardization. Standardizing herbal medicines is essential to ensure their quality, purity, efficacy, and safety. Herbal medicines are widely used due to their easy availability and minimal side effects. These remedies have been passed down through generations, holding cultural and holistic significance—for example, the Amla plant. However, to ensure consistency and reliability, it is vital to establish standardized procedures for herbal formulations. This study emphases on the standardization of Amla Churna following WHO guidelines. Amla Churna is a well-known herbal formulation used to Enhance immunity, Anti-oxidant and digestive issues. In this study, the prepared Amla Churna was compared with a commercially available sample (Patanjali Amla Churna). Various standardization techniques were applied, including macroscopic and microscopic analysis, powder flow properties, extractive values, physicochemical characterization, heavy metal detection, and qualitative and quantitative tests for tannins and alkaloids. Additionally, TLC fingerprinting was conducted to assess the formulation’s quality, safety, and therapeutic efficacy. Formulated churna passed the tests according to all parameters, due to these it is conclude that formulated churna is also acceptable as compare with marketed churna.
Cite this article:
Saloni A Pande, Aakansha S Patil, Aishwarya S Patil, Junaid S Shaikh. Comparative Study of Herbal Formulation and Marketed Formulation of Amla (Emblica officinalis) Churna. Research Journal of Pharmacognosy and Phytochemistry. 2025; 17(2):111-5. doi: 10.52711/0975-4385.2025.00019
Cite(Electronic):
Saloni A Pande, Aakansha S Patil, Aishwarya S Patil, Junaid S Shaikh. Comparative Study of Herbal Formulation and Marketed Formulation of Amla (Emblica officinalis) Churna. Research Journal of Pharmacognosy and Phytochemistry. 2025; 17(2):111-5. doi: 10.52711/0975-4385.2025.00019 Available on: https://rjpponline.org/AbstractView.aspx?PID=2025-17-2-6
7. REFERENCES:
1. Mishra L, Singh BB, Dagenais S. Ayurveda: A historical perspective and principles of the traditional healthcare system in India. Alternative Therapies in Health and Medicine. 2001; 7(2):36-42.
2. Chopra A, Doiphode VV. Ayurvedic medicinecore concept, therapeutic principles, and current relevance. Medical Clinics of North America. 2002; 86(1):75-88.
3. Zaveri M, Khandhar A, Patel S, Patel A. Chemistry and pharmacology of Piper longum L. International Journal of Pharmaceutical Sciences Review and Research. 2010 Nov;5(1):67-76.
4. World Health Organization. Quality control methods for medicinal plant materials. World Health Organization; 1998.
5. Vikas Sharma*, Rahul Kaushik, Pallavi Rai, “Comparative Study of Herbal Formulation and Marketed Formulation of Triphala Churna”, “International Journal of Pharmaceutical Education And Research (IJPER)” June-2020 Page No.21-29
6. Dr. C.K. Kokate, A.P. Purohit, S.B. Gokhale, “Book Of Pharmacognocy”,50th edition, Sept 2014,Nirali Publication ,page no.=10.4-10.5.
7. “Dr. K. R. Khandelwal, Dr. Vrinda K. Sethi”, “Practical book of Pharmacognancy” ,24th edition august 2014 Nirali prakashan, pg no :157 to 160
8. Anonymous: Indian Pharmacopoeia, Government of India, Ministry of health, Controller of publication, Delhi, India,1996.
9. Ministry of Health and Family Welfare. (1986). The Ayurvedic Pharmacopoeia of India (Part I, Vol. I, pp. 1–2).
10. “Vinod.D. Rangari” Book of Pharmacognocy and Phytochemistry”, volume 2, 1st edition, march 2003, Career publication pg . no:25.9